Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02914639
What this trial is testing

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
OcuTerra Therapeutics, Inc. 44
Large-scale testing (Phase 3)WithdrawnNCT02229175
What this trial is testing

Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
University of California, San Francisco
Early research (Phase 1)Study completedNCT04014777
What this trial is testing

Study of NGM621 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
NGM Biopharmaceuticals, Inc 15
Testing effectiveness (Phase 2)Study completedNCT04585893
What this trial is testing

Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Who this might be right for
Multicentric Castleman Disease
UNC Lineberger Comprehensive Cancer Center 15
Post-approval studies (Phase 4)Looking for participantsNCT06850571
What this trial is testing

Aflibercept and Bevacizumab for Diabetic Maculopathies

Who this might be right for
Diabetic Maculopathy
Al-Mustansiriyah University 102
Early research (Phase 1)Study completedNCT02076919
What this trial is testing

First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Alcon Research 110
Post-approval studies (Phase 4)Study completedNCT00406107
What this trial is testing

Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Palmetto Retina Center, LLC 20
Not applicableLooking for participantsNCT06000111
What this trial is testing

Duration of Face Down Positioning for Full-Thickness Macular Hole Repair

Who this might be right for
Macular Holes
St. Joseph's Healthcare Hamilton 40
Testing effectiveness (Phase 2)Study completedNCT00088283
What this trial is testing

Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Eyetech Pharmaceuticals 90
Not applicableStudy completedNCT07206654
What this trial is testing

Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision

Who this might be right for
Visual ImpairmentAge-Related Macular Degeneration (AMD)Musculoskeletal Pain+2 more
Beni-Suef University 100
Not applicableEnded earlyNCT02088151
What this trial is testing

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Who this might be right for
Macular EdemaCentral Serous ChorioretinopathyRetinal Vein Occlusion+2 more
Insel Gruppe AG, University Hospital Bern 18
Large-scale testing (Phase 3)Study completedNCT00042211
What this trial is testing

Preventing Depression in Patients With Macular Degeneration

Who this might be right for
DepressionMacular Degeneration
Thomas Jefferson University 206
Not applicableStudy completedNCT02073266
What this trial is testing

Impact of C3F8 or SF6 Use and Length of Face-down Positioning (7 vs 14 Days Respectively) in Macular Hole Surgery

Who this might be right for
Macular HolesVisual Acuity GainCataract+1 more
CHU de Quebec-Universite Laval 59
Testing effectiveness (Phase 2)Looking for participantsNCT06825702
What this trial is testing

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

Who this might be right for
Macular Edema
Kiora Pharmaceuticals, Inc. 28
Not applicableUnknownNCT04739137
What this trial is testing

Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients

Who this might be right for
Low VisionMacular EdemaRefractive Errors
Democritus University of Thrace 300
Not applicableLooking for participantsNCT05976139
What this trial is testing

Micropulsed Laser in Patients With Macular Oedema in Retinal Dystrophies

Who this might be right for
Macular EdemaInherited Retinal DystrophyLaser Retinopathy
Fondazione G.B. Bietti, IRCCS 10
Not applicableStudy completedNCT01832077
What this trial is testing

Uptake of Telemedicine System Trial in Rual Canton

Who this might be right for
Diabetes RetinopathyDiabetes Macular Edema
Sun Yat-sen University 5,000
Not applicableUnknownNCT00443911
What this trial is testing

Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 20
Post-approval studies (Phase 4)UnknownNCT04501367
What this trial is testing

Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

Who this might be right for
VitrectomyMacular PuckerRetinal Edema
Kovach Eye Institute 60
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Next Page